Muscle optimization device and method

Inventors

Gangwish, Kimberly S.Moddel, Garret

Assignees

Genovus Biotechnologies Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11246799-B2

Patent

Publication Date

2022-02-15

Expiration Date


Abstract

A device and method are provided for therapy and treatment of biological tissue such as muscle, tendon, and ligament tissue, by use of a device and method in which therapeutic vibrational frequency resonance patterns are transmitted to tissues of a patient. The resonance frequencies originate from many resonance domains, including vitamins, minerals, herbs, amino acids, and fatty acids. Each domain includes therapeutic frequency resonance patterns. These resonance patterns may be passively excited and transmitted to a patient to enhance tissue function, to decrease the normal rehabilitation time of damaged tissue, and provide therapeutic benefits for muscle tissue dysfunction. Therapeutic frequency resonance patterns may also be actively excited by a delivery mechanism that uses electromagnetic or mechanical waves to interact with the device. The actively excited device transmits the therapeutic frequency resonance patterns to the patients for similar enhancements and therapeutic benefits.

Core Innovation

The invention provides a therapeutic frequency resonance pattern device for treatment of biological tissue by application of therapeutic frequency patterns. The device comprises a substrate layer and a mineral matrix layer having at least one resonance frequency imbedded therein, and the resonance frequency is excited using a wave produced by a delivery mechanism. The method places the device in proximity to a muscle of a patient and uses a wave comprising at least one of a mechanical wave and an electromagnetic wave to excite the at least one resonance frequency of the mineral matrix layer.

After exciting the at least one resonance frequency, the method removes the device from proximity with the patient and tests the muscle to confirm that a therapeutic effect has been achieved. The independent claim structure is centered on proximity placement, excitation of imbedded resonance frequencies in the mineral matrix layer, removal, and post-treatment muscle testing to confirm a therapeutic effect.

The claimed device substrate layer is defined to include one or more of piezoelectric crystal, quartz, silicon, and crystal cut, with an extended list in dependent claim language allowing multiple crystal and materials and combinations thereof. Additional device structure refinements include providing a protective layer placed over the mineral matrix layer. Further refinements specify delivery mechanisms and wave characteristics, including electromagnetic and mechanical excitation modalities, and impose quantitative frequency constraints and permissible waveform shapes for the produced wave.

Claims Coverage

The document includes two independent claims that share the core sequence of providing a therapeutic frequency resonance pattern device, placing it near a patient muscle, exciting an imbedded mineral-matrix resonance frequency using a wave produced nearby, removing the device, and testing the muscle to confirm a therapeutic effect. Across the dependent claim set referenced in the partial content, the inventive features additionally constrain substrate composition, protective layers, waveform types, delivery modalities, and frequency thresholds/ranges.

Therapeutic frequency resonance pattern device for muscle treatment

Providing a therapeutic frequency resonance pattern device comprising a substrate layer and a mineral matrix layer having at least one resonance frequency imbedded therein, where the method places the device in proximity to a muscle of a patient and uses the delivery mechanism to excite the imbedded resonance frequency.

Exciting imbedded mineral-matrix resonance using nearby mechanical or electromagnetic waves

Exciting the at least one resonance frequency of the mineral matrix layer using a wave produced by the delivery mechanism, the wave comprising at least one of a mechanical wave and an electromagnetic wave.

Removal and muscle testing to confirm therapeutic effect

Removing the device from proximity with the patient and testing the muscle to confirm a therapeutic effect has been achieved.

Substrate layer comprising specified piezoelectric crystal or quartz-based components

Providing the therapeutic frequency resonance pattern device where the substrate layer comprises one of a piezoelectric crystal, quartz, silicon, crystal cut, synthetic crystal, and combinations thereof.

Protective layer over mineral matrix layer

Providing a device that includes a protective layer placed over the mineral matrix layer.

Waveform selection for the delivered wave

The wave used includes a waveform that is at least one of a sine wave, a square wave, a triangle wave, or a sawtooth wave.

Frequency constraints for electromagnetic or acoustic excitation

Confining the excitation or produced signal using quantitative frequency constraints, including at least the dependent claim recited ranges such as a tuning fork acoustic resonator frequency range between 62 Hz and 4111 Hz, a frequency range between 7.83 Hz and 33.8 Hz, and dependent thresholds for TENS and PEMF described in the partial content.

Overall claim coverage centers on a therapeutic frequency resonance pattern device with a mineral matrix embedding resonance frequencies, excited by mechanical and/or electromagnetic waves delivered in proximity to a patient muscle. Claim coverage further specifies permitted substrate compositions, optional protective-layer structure, possible waveform types, and quantitative frequency constraints tied to the delivery mechanism, followed by device removal and muscle testing to confirm a therapeutic effect.

Stated Advantages

Claims and described testing support confirmation that a therapeutic effect has been achieved through muscle testing.

Proof-of-concept results described in the partial content indicate increased motor unit recruitment/peak force and changes in EMG RMS, with reported long-lasting improvements in mobility and pain.

Documented Applications

Treatment of biological tissue by application of therapeutic frequency patterns, specifically in proximity to a muscle of a patient, with muscle testing to confirm a therapeutic effect.

Therapeutic use described in the partial content includes mobility and pain improvements reported as long-lasting improvements.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.